NeoCore Technology Co., Ltd. (4131) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NeoCore Technology Co., Ltd. (4131:TWSE), powered by AI.

Current Price
$37.90
P/E Ratio
-30.7
Market Cap
1.5B
Sector
Healthcare
What is the NeoCore Technology Co., Ltd. stock price forecast?

NeoCore Technology Co., Ltd. is currently trading at $37.90. View real-time AI analysis on Alpha Lenz.

What is NeoCore Technology Co., Ltd. insider trading activity?

View the latest insider trading data for NeoCore Technology Co., Ltd. on Alpha Lenz.

What is NeoCore Technology Co., Ltd.'s P/E ratio?

NeoCore Technology Co., Ltd.'s P/E ratio is -30.7.

NeoCore Technology Co., Ltd.

TWSE · 4131
NT$37.90+0.40(+1.07%)
Ask about NeoCore Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

NeoCore Technology Co., Ltd. trades at a P/E of -30.7 (undervalued) with modest ROE of -14.7%.

Ask for details

Company Overview

NeoCore Technology Co., Ltd. is a biotechnology company specializing in the research, development, and manufacturing of biochips and advanced diagnostic solutions. Its primary function is to provide innovative products for food safety testing, human diagnostics, agricultural analysis, and laboratory automation, supporting sectors such as healthcare, biotechnology, and food safety. With a diverse portfolio that includes DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization devices, and various biomedical reagents, NeoCore Technology enables efficient and accurate biological detection and analysis. The company also extends its reach through the wholesale and retail of contact lenses and various laboratory planning and design services. Founded in 1987 and headquartered in Tainan, Taiwan, NeoCore Technology plays a significant role in both domestic and regional markets, serving clients throughout Asia and Europe. The company's focus on biotechnology innovation supports advancements in medical diagnostics and bioanalysis, positioning it as a specialized player in the medical and biotechnology industries.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2024

Profile

NT$1.48BMarket Cap
NT$61.55MRevenue
0.00Shares Out
0Employees

Margins

5.35%Gross
-78.59%EBITDA
-123.22%Operating
-92.44%Pre-Tax
-92.44%Net

Valuation

-30.71P/E
4.84P/B
24.02EV/Sales
-26.77EV/EBITDA
-21.22P/FCF

Growth (CAGR)

-11.55%Rev 3Yr
-10.05%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-12.79%ROA
-14.75%ROE
-12.32%ROIC

Financial Health

NT$207.99MCash & Cash Equivalents
NT$-172.32MNet Debt
11.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

NeoCore Technology Co., Ltd. (ticker: 4131) is a company listed on TWSE in the Healthcare sector (Biotechnology). Market cap is $1.5B.

The current price is 37.9 with a P/E ratio of -30.71x and P/B of 4.84x.

ROE is -14.75% and operating margin is -123.22%. Annual revenue is $62M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
NeoCore Technology Co., Ltd. (4131) Stock Forecast 2026 $37.90 — Price, Financials & Analyst Targets | Alpha Lenz